Amex GBT’s Qualantone Sets June 30 Retirement Date
American Express Global Business Travel chief revenue officer Michael Qualantone will retire next year after 34 years with the company, Amex GBT announced this week.Qualantone will stay with…
Browsing Tag
GBTs
MHRA Grants Marketing Authorization for GBT’s Oxbryta® (voxelotor) for Use in Great…
SOUTH SAN FRANCISCO, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that the Medicines and Healthcare products Regulatory…
Positive Early Access to Medicines Scheme (EAMS) Scientific Opinion Awarded to GBT’s…
LONDON, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics (GBT) today announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has awarded a positive…
GBT’s Oxbryta® (voxelotor) Receives Positive CHMP Opinion for the Treatment of…
European Commission decision on marketing authorization anticipated first quarter of 2022 Oxbryta would be the first oral treatment available in Europe to directly inhibit sickle…
GBT’s Voxelotor is First Sickle Cell Disease Treatment to Receive Promising…
SOUTH SAN FRANCISCO, Calif. and LONDON, June 14, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT), a biopharmaceutical company dedicated to the discovery,…